Match!

Nonalcoholic fatty liver disease, association with cardiovascular disease and treatment (II). The treatment of nonalcoholic fatty liver disease

Published on Jul 1, 2017
· DOI :10.1016/j.artere.2017.07.001
Ángel Brea9
Estimated H-index: 9
,
Xavier Pintó41
Estimated H-index: 41
+ 7 AuthorsJuan Pedro-Botet30
Estimated H-index: 30
(Autonomous University of Barcelona)
Abstract
Disease nonalcoholic fatty liver disease (NAFLD) comprises a series of histologically similar to those induced by alcohol consumption in people with very little or no liver damage same. The importance of NAFLD is its high prevalence in our Western societies, from the point of view liver in its progressive evolution from steatosis to steatohepatitis, cirrhosis and liver cancer. During the last decade it has been observed that NAFLD leads to an increased cardiovascular risk with accelerated atherosclerosis and cardiovascular events, the leading cause of morbidity and mortality. This updated January 2016 revision consists of two parts. In this second part, the treatment of NAFLD and its influence on cardiovascular disease and drugs used in the control of cardiovascular risk factors showing a beneficial effect on the liver disease will be reviewed.
  • References (210)
  • Citations (1)
References210
Newest
#1Matthew J. Armstrong (NIHR: National Institute for Health Research)H-Index: 24
#2Piers Gaunt (University of Birmingham)H-Index: 5
Last.Philip N. Newsome (NIHR: National Institute for Health Research)H-Index: 34
view all 16 authors...
#1Matthew J. Armstrong (University of Birmingham)H-Index: 24
#2D. Hull (University of Birmingham)H-Index: 10
Last.Jeremy W. Tomlinson (University of Oxford)H-Index: 46
view all 11 authors...
#1Guy Bower (Imperial College London)H-Index: 2
#2Tania Toma (Imperial College London)H-Index: 4
Last.Hutan Ashrafian (Imperial College London)H-Index: 32
view all 8 authors...
#1Shelley E. Keating (UQ: University of Queensland)H-Index: 11
#2Jacob George (USYD: University of Sydney)H-Index: 86
Last.Nathan A. Johnson (USYD: University of Sydney)H-Index: 25
view all 3 authors...
#1Kareem SalhiyyahH-Index: 3
#2Rachel Forster (Edin.: University of Edinburgh)H-Index: 6
Last.Jonathan Michaels (University of Sheffield)H-Index: 29
view all 6 authors...
#1Paola DongiovanniH-Index: 39
#2Salvatore Petta (University of Palermo)H-Index: 41
Last.Luca Valenti (University of Milan)H-Index: 48
view all 19 authors...
View next paperNonalcoholic fatty liver disease, association with cardiovascular disease and treatment. (i). Nonalcoholic fatty liver disease and its association with cardiovascular disease ☆